We are live on
!
Find out more
NED
Nancy E. Dempze Portfolio holdings
AUM
$182M
1-Year Est. Return
16.09%
This Fund
S&P 500
This Quarter
Est. Return
+7.39%
1 Year Est. Return
+16.09%
3 Year Est. Return
+59.1%
5 Year Est. Return
+78.95%
10 Year Est. Return
+300.76%
AUM
$117M
AUM Growth
+$6.72M
(+6.1%)
Cap. Flow
-$723K
Cap. Flow
% of AUM
-0.62%
Top 10 Holdings %
Top 10 Hldgs %
37.32%
Holding
65
New
–
Increased
23
Reduced
24
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$214K |
| 2 |
RTX Corp
RTX
|
+$142K |
| 3 |
UnitedHealth
UNH
|
+$141K |
| 4 |
Chevron
CVX
|
+$123K |
| 5 |
Johnson & Johnson
JNJ
|
+$122K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever
UL
|
+$781K |
| 2 |
PayPal
PYPL
|
+$460K |
| 3 |
Honeywell
HON
|
+$387K |
| 4 |
Aptiv
APTV
|
+$215K |
| 5 |
Apple
AAPL
|
+$209K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.14% |
| 2 | Healthcare | 21.97% |
| 3 | Industrials | 12.92% |
| 4 | Consumer Discretionary | 8.74% |
| 5 | Financials | 5.16% |
Similar funds
RS
CFG
CFG
TFP
AFS
EMB
CIA
HWM
Nancy E. Dempze's Q2 2023 Portfolio in Review
As of Q2 2023, Nancy E. Dempze held 65 positions worth $117M, up 6.1% from $110M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Trading was light in Q2 2023: portfolio turnover was 3.1%. Nancy E. Dempze opened no new positions and exited 2, leaving the 65-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.
- Nancy E. Dempze added most to Medtronic in Q2 2023, an estimated $214K increase.
- Nancy E. Dempze's biggest Q2 2023 reduction was Unilever, cutting an estimated $781K.
- Nancy E. Dempze fully exited PayPal in Q2 2023, selling an estimated $460K.
- Nancy E. Dempze's ten largest holdings make up 37% of its $117M portfolio in Q2 2023.
- Nancy E. Dempze opened 0 new positions and closed 2 in Q2 2023.
- Nancy E. Dempze's portfolio value rose 6.1% quarter-over-quarter to $117M.
Based on Nancy E. Dempze's 13F filing for Q2 2023, filed 14 Aug 2023.